Frontlight ResearchEarly access
Trial site
Recherches Neuro-Hippocampe, Inc., d/b/a Ottawa Memory Clinic
- 2running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease7 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Terminated3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Suspended1 trial
- Lead sponsor
- Alzheon Inc.2 trials
- Biogen2 trials
- Cassava Sciences, Inc.1 trial
- Eisai Inc.1 trial
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
Running trials
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Closed trials
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Site data: ClinicalTrials.govUpdated 12 Nov 2026